证券日报网讯广康生化（300804）7月31日在互动平台回答投资者提问时表示，公司目前未直接面向终 端市场销售卫生用药产品。该类产品主要供应给跨国企业，由其负责后续的对外销售，相关收入在公司 整体营收中占比较小。经核实，公司目前拥有登记证号WP开头的产品6个。 ...

Group 1 - The company, Guangkang Biochemical (300804.SZ), does not sell sanitary pharmaceuticals directly to the end market, instead supplying these products to multinational companies responsible for external sales [1] - The revenue from sanitary pharmaceuticals constitutes a small proportion of the company's overall revenue [1] - The company currently holds six product registration numbers starting with WP [1] Group 2 - An investor inquired about the company's registration and business situation in the sanitary pharmaceutical sector, specifically regarding three registered products for mosquito control [3] - The registered products include cis-chlordimeform suspension agent, wettable powder, and high-efficiency chlordimeform suspension agent [3] - The company's previous statements indicated a lack of relevant registration qualifications and plans in the sanitary pharmaceutical field, prompting the need for clarification [3]